- Home
- AXR vs TARA Comparison
AXR vs TARA Comparison
Compare AXR & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXR
- TARA
- Stock Information
- Founded
- AXR 1961
- TARA N/A
- Country
- AXR United States
- TARA United States
- Employees
- AXR N/A
- TARA N/A
- Industry
- AXR Homebuilding
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXR Real Estate
- TARA Health Care
- Exchange
- AXR Nasdaq
- TARA Nasdaq
- Market Cap
- AXR 117.0M
- TARA 118.1M
- IPO Year
- AXR N/A
- TARA N/A
- Fundamental
- Price
- AXR $24.19
- TARA $3.16
- Analyst Decision
- AXR
- TARA Strong Buy
- Analyst Count
- AXR 0
- TARA 6
- Target Price
- AXR N/A
- TARA $19.80
- AVG Volume (30 Days)
- AXR 11.4K
- TARA 140.5K
- Earning Date
- AXR 09-09-2025
- TARA 11-11-2025
- Dividend Yield
- AXR N/A
- TARA N/A
- EPS Growth
- AXR 40.98
- TARA N/A
- EPS
- AXR 2.48
- TARA N/A
- Revenue
- AXR $48,454,000.00
- TARA N/A
- Revenue This Year
- AXR $12.31
- TARA N/A
- Revenue Next Year
- AXR $8.40
- TARA N/A
- P/E Ratio
- AXR $9.67
- TARA N/A
- Revenue Growth
- AXR N/A
- TARA N/A
- 52 Week Low
- AXR $17.60
- TARA $1.60
- 52 Week High
- AXR $39.68
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- AXR 66.40
- TARA 51.06
- Support Level
- AXR $20.57
- TARA $3.05
- Resistance Level
- AXR $24.99
- TARA $3.24
- Average True Range (ATR)
- AXR 1.23
- TARA 0.13
- MACD
- AXR 0.30
- TARA 0.00
- Stochastic Oscillator
- AXR 84.16
- TARA 42.86
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).